Immunocore Holdings (IMCR) Debt to Equity (2022 - 2025)
Historic Debt to Equity for Immunocore Holdings (IMCR) over the last 4 years, with Q3 2025 value amounting to $0.99.
- Immunocore Holdings' Debt to Equity fell 421.27% to $0.99 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.99, marking a year-over-year decrease of 421.27%. This contributed to the annual value of $1.08 for FY2024, which is 73277.29% up from last year.
- As of Q3 2025, Immunocore Holdings' Debt to Equity stood at $0.99, which was down 421.27% from $1.01 recorded in Q2 2025.
- Immunocore Holdings' Debt to Equity's 5-year high stood at $1.22 during Q2 2024, with a 5-year trough of $0.13 in Q4 2023.
- Its 4-year average for Debt to Equity is $0.87, with a median of $1.03 in 2024.
- As far as peak fluctuations go, Immunocore Holdings' Debt to Equity surged by 73277.29% in 2024, and later tumbled by 1727.27% in 2025.
- Immunocore Holdings' Debt to Equity (Quarter) stood at $0.14 in 2022, then decreased by 7.73% to $0.13 in 2023, then surged by 732.77% to $1.08 in 2024, then dropped by 8.67% to $0.99 in 2025.
- Its Debt to Equity was $0.99 in Q3 2025, compared to $1.01 in Q2 2025 and $1.03 in Q1 2025.